Study Design and Intervention
This was a single-center prospective single-arm interventional study. All 16 patients undergoing outpatient hemodialysis at our hemodialysis center as of November 1, 2019, were selected for enrollment into this study. Exclusion criteria were as follows: cases for which we were unable to obtain consent and cases with severe cardiac illnesses (acute myocardial infarction, unstable angina, arrhythmia with hemodynamic abnormalities, and advanced aortic stenosis). We obtained written, informed consent from all participants. None of the 16 selected participants met any of these exclusion criteria.
The intervention in this study was thrice-weekly intradialytic (i.e., during hemodialysis) exercise therapy. Patients underwent 50 minutes of exercise therapy during each of their three weekly hemodialysis visits. Exercise therapy began one hour after dialysis therapy had begun, and consisted of 10 minutes of stretching, 20 minutes of aerobic exercise using an ergometer at a rating of perceived exertion (RPE) of 13 (“somewhat hard”), and 20 minutes of resistance training using elastic bands and weights at a RPE of 13. Resistance training consisted of shoulder flexion/abduction, hip flexion/abduction, knee extension, and back bridge exercises, with 20 repetitions constituting one set of each exercise. Dedicated physical therapists were present to monitor exercise sessions and offer advice. In order to prevent the spread of COVID-19, dialysis staff, physical therapists, and patients were all subjected to daily morning measurements of body temperature, asked to wear masks, requested to follow cough etiquette, and to practice good handwashing. Staff that developed fever-like symptoms were instructed to stay at home until the possibility of COVID-19 infection could be ruled out. Patients that developed fever-like symptoms had their dialysis treatments adjusted so as not to occur alongside any other patients, and received dialysis therapy in a private room, and had their intradialytic exercise therapy postponed.4,5 This study was registered with the Japanese University Hospital Medical Information Network Clinical Trials Registry (UMIN 000038313). The study protocol used herein was approved by the Internal Review Board of the Teine Keijinkai Medical Center (IRB Approval No. 2-019071-00) and was carried out in accordance with the Declaration of Helsinki.
Data Collection
We recorded information on patients’ demographic characteristics, history of dialysis, comorbidities, number of medications currently being taken, social frailty status, physical function, muscle strength, and muscle mass.
Social Frailty
In keeping with the approach taking by Makizako et al., we evaluated patients’ social frailty status by asking five questions.1 These were as follows: (1) Do you go out less often now than you did a year ago? (2) Do you rarely visit the homes of your friends? (3) Do you feel that you are unhelpful to your family and friends? (4) Do you live alone? (5) Do you not have the opportunity to speak to someone every day? Patients that answered “Yes” to two or more of these questions were categorized as socially frail.
Measurement of Outcome
Patients were measured at baseline and after three months of therapy. Measurements of physical function were carried out on dialysis therapy days before dialysis. Outcomes of this study were improvements in patients’ walking speed, physical function, muscle strength, muscle mass, and social frailty status after three months of treatment.
Physical Function and Muscle Strength
Physical function was evaluated via walking speed and the Short Physical Performance Battery (SPPB). Walking speed was measured as patients’ normal walking speed, without speeding up or slowing down, over a distance of four meters. Speeds of 0.8 m/s or lower were defined as reduced walking speed.3 The SPPB was carried out in accordance with the standard method: patients were given scores from 0–4 based on their performance in each of three tasks: balance test, gait speed test, chair stand test. These three scores were totaled to yield a composite score.6 Muscle strength was evaluated as grip strength, which was measured while the patient was standing with their arms extended. Left and right arms were each measured twice, and the highest value was recorded.
Muscle Mass
Muscle mass was evaluated using the appendicular skeletal muscle mass index (ASMI). First, patient muscle mass was recorded using bioelectrical impedance analysis (BIA), which was then divided by the patient’s height in meters and squared to yield an ASMI value.
Statistical Analysis
Normal distribution was assessed by the Shapiro-Wilk test. Continuous variables are expressed as means and standard deviation (SD) or median and interquartile range (IQR: 25–75th percentile) depending on the results of the Shapiro-Wilk test. Categorical variables were expressed as frequency and percentage. Differences in continuous variables between patients with social frailty and those without were tested by Student’s t-test or the Mann–Whitney U test. Differences in continuous variables within a group were tested by paired t-test or the Wilcoxon signed-rank test. Differences in categorical variables between patients with social frailty and patients without were analyzed by Fisher’s test. Differences in categorical variables within a group were tested by McNemar test. Spearman’s rank correlation was used to determine the relationship between the gait speed and the social frailty score. A probability value of < 0.05 was considered to be statistically significant. Statistical analysis was performed using EZR software (Jichi Medical University, Saitama, Japan).